114 related articles for article (PubMed ID: 10550714)
1. Analysis of mutant p53 and telomerase activity in non-small cell lung cancer.
Kiyooka K; Maniwa Y; Okada M
Ann Thorac Cardiovasc Surg; 1999 Oct; 5(5):293-9. PubMed ID: 10550714
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
Wang J; Liu X; Jiang W; Liang L
Chin Med J (Engl); 2000 Nov; 113(11):985-90. PubMed ID: 11776132
[TBL] [Abstract][Full Text] [Related]
3. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
4. [Study on telomerase activity and its clinical value in human non small cell lung cancer].
Chen Q; He J; Yi H
Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):221-2. PubMed ID: 12536686
[TBL] [Abstract][Full Text] [Related]
5. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.
Ahrendt SA; Yang SC; Wu L; Westra WH; Jen J; Califano JA; Sidransky D
Clin Cancer Res; 1997 Jul; 3(7):1207-14. PubMed ID: 9815801
[TBL] [Abstract][Full Text] [Related]
6. Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance.
Li W; Ni Y; Tu Z; Wu S; Wu Z; Zheng S
Eur J Cardiothorac Surg; 2009 Sep; 36(3):460-4. PubMed ID: 19502078
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
Ohmura Y; Aoe M; Andou A; Shimizu N
Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of telomerase reverse transcriptase and its regulators in non-small cell lung carcinoma].
Chen TX; Xiong YY; Liu L
Ai Zheng; 2004 Mar; 23(3):273-7. PubMed ID: 15025956
[TBL] [Abstract][Full Text] [Related]
9. [Detection of telomerase activity level in human non-small-cell lung cancer].
Yang HZ; Hu CP; Su XL
Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):549-50. PubMed ID: 12536537
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity in transthoracic fine-needle biopsy aspirates from non-small cell lung cancer as prognostic factor of patients' survival.
Targowski T; Jahnz-Rózyk K; Szkoda T; Płusa T; From S
Lung Cancer; 2008 Jul; 61(1):97-103. PubMed ID: 18063440
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
Swellam M; Ismail M; Eissa S; Hamdy M; Mokhtar N
IUBMB Life; 2004 Aug; 56(8):483-90. PubMed ID: 15545228
[TBL] [Abstract][Full Text] [Related]
12. [Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer].
Wang J; Liu X; Jiang W
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):289-92. PubMed ID: 11783109
[TBL] [Abstract][Full Text] [Related]
13. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in sputum and telomerase and its components in biopsies of advanced lung cancer.
Pasrija T; Srinivasan R; Behera D; Majumdar S
Eur J Cancer; 2007 Jun; 43(9):1476-82. PubMed ID: 17531468
[TBL] [Abstract][Full Text] [Related]
15. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
Schneider PM; Praeuer HW; Stoeltzing O; Boehm J; Manning J; Metzger R; Fink U; Wegerer S; Hoelscher AH; Roth JA
Br J Cancer; 2000 Aug; 83(4):473-9. PubMed ID: 10945494
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and serum levels of p53 protein as prognostic factors of survival in patients with advanced non-small cell lung cancer.
Targowski T; Jahnz-Rozyk K; Owczarek W; Raczka A; Janda P; Szkoda T; Płusa T
Respir Med; 2010 Sep; 104(9):1356-61. PubMed ID: 20363608
[TBL] [Abstract][Full Text] [Related]
17. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H
Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215
[TBL] [Abstract][Full Text] [Related]
18. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in endoscopically visible lung cancer.
Hirashima T; Yoshitaka O; Nitta T; Sasada S; Kobayashi M; Masuda N; Matsui K; Nakagawa K; Yasumitsu T; Takada Y; Kikui M; Kawase I
Anticancer Res; 2001; 21(5):3685-9. PubMed ID: 11848543
[TBL] [Abstract][Full Text] [Related]
20. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
Hsu CP; Hsu NY; Lee LW; Ko JL
Eur J Cancer; 2006 Jul; 42(10):1466-74. PubMed ID: 16737810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]